Details of the Drug
General Information of Drug (ID: DM7AW0X)
| Drug Name |
Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
[5-hydroxy-6-methyl-4-[[(3-oxo-1,2-oxazolidin-4-yl)amino]methyl]pyridin-3-yl]methyl dihydrogen phosphate; (5-hydroxy-6-methyl-4-{[(3-oxo-1,2-oxazolidin-4-yl)amino]methyl}pyridin-3-yl)methyl dihydrogen phosphate; AC1L1ESQ; PYRIDOXYL-N,O-CYCLOSERYLAMIDE-5-MONOPHOSPHATE; CTK7H6662; L-PYRIDOXYL-N,O-CYCLOSERYLAMIDE-5-MONOPHOSPHATE; L-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE; [3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE; Phosphoric acid [4-[[(3-o
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 333.23 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -4.8 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 6 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 5 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 9 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


